Esmolol patient counseling information: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) |
||
| Line 6: | Line 6: | ||
Physicians should inform patients of the risks associated with BREVIBLOC injection: | Physicians should inform patients of the risks associated with BREVIBLOC injection: | ||
The most common adverse reactions are : | The most common adverse reactions are : | ||
:*Symptomatic [[hypotension]] (hyperhidrosis, dizziness) | :*Symptomatic [[hypotension]] ( hyperhidrosis, [[dizziness]] ) | ||
:*Asymptomatic hypotension.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher = | date = | accessdate = }}</ref> | :*Asymptomatic hypotension.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
Revision as of 21:55, 4 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Patient Counseling Information
Physicians should inform patients of the risks associated with BREVIBLOC injection: The most common adverse reactions are :
- Symptomatic hypotension ( hyperhidrosis, dizziness )
- Asymptomatic hypotension.[1]
References
Adapted from the FDA Package Insert.